EvoMuse AlphaBurn
- Thread starter dsade
- Start date
fatburner2007
Well-known member
howwedo107
Well-known member
Sweet!! Stackable with VL?
dsade
NutraPlanet Fanatic
Stacks extremely well with Vanillean, given the central action of TRPV1 agonists and release of adrenergic catecholamines. Add some green tea, too, for a great stack.
MidwestBeast
Legend
Very excited the time has finally come!
fatburner2007
Well-known member
RickyBDragon
Banned
Seeing as this wasn't up yesterday, will AlphaBurn be available within the next couple of days?
howwedo107
Well-known member
Any logging chances for this puppy?
MidwestBeast
Legend
Geoforce
Well-known member
Should be up anytime really. If it isn't then I can't see it going past tomorrow. I believe NP has it now.
dsade
NutraPlanet Fanatic
I've been using the same supplier since I introduced alpha yohimbine to the market back in 2003.
I researched it and had it custom extracted because I have no tolerance for Yohimbine.
howwedo107
Well-known member
Wow! I want to throw this in with my VL log! That'd be a sick stack! And it's all non stim dsade doing it big bro if I wasn't such a stickler about shipping I'd pick up a bottle right now but ill have to wait until I put in my next order awesome stuff by the looks of it
dsade
NutraPlanet Fanatic
Invalid Link Removed, Invalid Link Removed, Invalid Link Removed, Invalid Link Removed, Invalid Link Removed, Invalid Link Removed, Invalid Link Removed BioMedical Centre, Department of Pharmaceutical Biosciences, Uppsala University, Sweden. [email protected]
Invalid Link Removed [1998, 343(1):93-101]
Type: Journal Article, Research Support, Non-U.S. Gov't, Comparative Study
DOI: 10.1016/S0014-2999(97)01521-5 Invalid Link Removed
[TABLE="width: 95%"]
[TR]
[TD="colspan: 2, align: left"] Abstract [/TD]
[TD="align: right"] Highlight Terms Invalid Link Removed Gene Ontology(2) Genes/Proteins(3) Species(5) Chemicals(7)
[/TD]
[/TR]
[/TABLE]
[TD="class: indented_text"]The Kd values of the recently introduced radioligand [3H]RS79948-197 ((8a R,12aS,13a-S)-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-metho xy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6] Invalid Link Removed ) were determined for the recombinant Invalid Link Removed and Invalid Link Removed alpha2A-, alpha2B- and alpha2C- as well as Invalid Link Removed alpha2B- and alpha2c-adrenoceptors expressed in COS (CV-1 Origin, Invalid Link Removed ) cells. In addition, the Kd values were also determined for [3H]RS79948-197 for the Invalid Link Removed spleen Invalid Link Removed and for Invalid Link Removed alpha2A-, alpha2B- and Invalid Link Removed in Invalid Link Removed obtained from kidney and striatum. Available radioligands for Invalid Link Removed , besides [3H]RS79948-197 are the tritiated forms of MK912 ((2S,12bS)1',3'-dimethylspiro(1,3,4,5',6,6',7,12b-octa hydro-2H-benzo furo[2,3-a]Invalid Link Removed)-2,4'-Invalid Link Removed-2'-one), RX821002 (2-Invalid Link Removed-Invalid Link Removed), Invalid Link Removed and Invalid Link Removed. In the present article the Invalid Link Removed constants of all these substances for the alpha2A-, alpha2B- and Invalid Link Removed subtypes in Invalid Link Removed, Invalid Link Removed, Invalid Link Removed and Invalid Link Removed are reviewed. In all species tested MK912 was alpha2C-selective, RX821002 showed a minor alpha2A-selectivity, whereas [3H]RS79948-197 was non-selective among the Invalid Link Removed subtypes, showing high affinity for all three subtypes. Invalid Link Removed and Invalid Link Removed showed relatively low affinities for nmost of the Invalid Link Removed subtypes investigated, the exception being Invalid Link Removed having high affinity for the Invalid Link Removed and porcine Invalid Link Removed
[/TD]
Invalid Link Removed [1998, 343(1):93-101]
Type: Journal Article, Research Support, Non-U.S. Gov't, Comparative Study
DOI: 10.1016/S0014-2999(97)01521-5 Invalid Link Removed
[TABLE="width: 95%"]
[TR]
[TD="colspan: 2, align: left"] Abstract [/TD]
[TD="align: right"] Highlight Terms Invalid Link Removed Gene Ontology(2) Genes/Proteins(3) Species(5) Chemicals(7)
[/TD]
[/TR]
[/TABLE]
[TD="class: indented_text"]The Kd values of the recently introduced radioligand [3H]RS79948-197 ((8a R,12aS,13a-S)-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-metho xy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6] Invalid Link Removed ) were determined for the recombinant Invalid Link Removed and Invalid Link Removed alpha2A-, alpha2B- and alpha2C- as well as Invalid Link Removed alpha2B- and alpha2c-adrenoceptors expressed in COS (CV-1 Origin, Invalid Link Removed ) cells. In addition, the Kd values were also determined for [3H]RS79948-197 for the Invalid Link Removed spleen Invalid Link Removed and for Invalid Link Removed alpha2A-, alpha2B- and Invalid Link Removed in Invalid Link Removed obtained from kidney and striatum. Available radioligands for Invalid Link Removed , besides [3H]RS79948-197 are the tritiated forms of MK912 ((2S,12bS)1',3'-dimethylspiro(1,3,4,5',6,6',7,12b-octa hydro-2H-benzo furo[2,3-a]Invalid Link Removed)-2,4'-Invalid Link Removed-2'-one), RX821002 (2-Invalid Link Removed-Invalid Link Removed), Invalid Link Removed and Invalid Link Removed. In the present article the Invalid Link Removed constants of all these substances for the alpha2A-, alpha2B- and Invalid Link Removed subtypes in Invalid Link Removed, Invalid Link Removed, Invalid Link Removed and Invalid Link Removed are reviewed. In all species tested MK912 was alpha2C-selective, RX821002 showed a minor alpha2A-selectivity, whereas [3H]RS79948-197 was non-selective among the Invalid Link Removed subtypes, showing high affinity for all three subtypes. Invalid Link Removed and Invalid Link Removed showed relatively low affinities for nmost of the Invalid Link Removed subtypes investigated, the exception being Invalid Link Removed having high affinity for the Invalid Link Removed and porcine Invalid Link Removed
[/TD]
dsade
NutraPlanet Fanatic
Invalid Link Removed
Long read, but goes into the functionality of the Alpha 2 subtypes, their physiological functions and locational prevalence, and their function, while blockaded by Alpha-Yohimbine, on both acute (fight or flight) and basal epinephrine and norepinephrine levels.
Long read, but goes into the functionality of the Alpha 2 subtypes, their physiological functions and locational prevalence, and their function, while blockaded by Alpha-Yohimbine, on both acute (fight or flight) and basal epinephrine and norepinephrine levels.
dsade
NutraPlanet Fanatic
The following menu user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Invalid Link Removed
[h=1]Invalid Link Removed[/h] Invalid Link Removed Invalid Link Removed
Search termSearch databaseThe following autocomplete user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Invalid Link RemovedInvalid Link Removed
[h=2]Result Filters[/h]
The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Invalid Link Removed[h=4]Invalid Link Removed[/h]
Invalid Link Removed[h=4]Invalid Link Removed[/h]
Invalid Link Removed 2002;109(4):819-26.
[h=1]Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.[/h]Invalid Link Removed, Invalid Link Removed, Invalid Link Removed.
[h=3]Source[/h]Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany.
[h=3]Abstract[/h]alpha(2)-Adrenergic receptors play an essential role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the CNS. However, the role of each of the three highly homologous alpha(2)-adrenergic receptor subtypes (alpha(2A), alpha(2B), alpha(2C)) in this process has not been determined unequivocally. To address this question, the regulation of norepinephrine and dopamine release was studied in mice carrying deletions in the genes encoding the three alpha(2)-adrenergic receptor subtypes. Autoradiography and radioligand binding studies showed that alpha(2)-receptor density in alpha(2A)-deficient brains was decreased to 9 +/- 1% of the respective wild-type value, whereas alpha(2)-receptor levels were reduced to 83 +/- 4% in alpha(2C)-deficient mice. These results indicate that approximately 90% of mouse brain alpha(2)-receptors belong to the alpha(2A) subtype and 10% are alpha(2C)-receptors. In isolated brain cortex slices from wild-type mice a non-subtype-selective alpha(2)-receptor agonist inhibited release of [(3)H]norepinephrine by maximally 96%. Similarly, release of [(3)H]dopamine from isolated basal ganglion slices was inhibited by 76% by an alpha(2)-receptor agonist. In alpha(2A)-receptor-deficient mice, the inhibitory effect of the alpha(2)-receptor agonist on norepinephrine and dopamine release was significantly reduced but not abolished. Only in tissues from mice lacking both alpha(2A)- and alpha(2C)-receptors was no alpha(2)-receptor agonist effect on transmitter release observed. The time course of onset of presynaptic inhibition of norepinephrine release was much faster for the alpha(2A)-receptor than for the alpha(2C)-subtype. After prolonged stimulation with norepinephrine, presynaptic alpha(2C)-adrenergic receptors were desensitized. From these data we suggest that two functionally distinct alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), operate as presynaptic inhibitory receptors regulating neurotransmitter release in the mouse CNS.
PMID:11927164 [PubMed - indexed for MEDLINE]
Alpha-2A and Alpha-2C blockade results in an increase in epinephrine/Norepinephrine, Basal Ganglia Dopamine, and serotonin levels. The primary perceived effect, for me, is an increase in motivation and goal-fulfillment actions.
The difference in affinities also can explain Alpha-Yohimbine's distinct lack of anxiety effects as compared to Yohimbine.
Invalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
[h=1]Invalid Link Removed[/h] Invalid Link Removed Invalid Link Removed
Search termSearch databaseThe following autocomplete user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Invalid Link RemovedInvalid Link Removed
- Invalid Link Removed
- Invalid Link Removed
[h=2]Result Filters[/h]
The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Invalid Link Removed[h=4]Invalid Link Removed[/h]
- Invalid Link Removed
Invalid Link Removed[h=4]Invalid Link Removed[/h]
Invalid Link Removed 2002;109(4):819-26.
[h=1]Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.[/h]Invalid Link Removed, Invalid Link Removed, Invalid Link Removed.
[h=3]Source[/h]Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany.
[h=3]Abstract[/h]alpha(2)-Adrenergic receptors play an essential role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the CNS. However, the role of each of the three highly homologous alpha(2)-adrenergic receptor subtypes (alpha(2A), alpha(2B), alpha(2C)) in this process has not been determined unequivocally. To address this question, the regulation of norepinephrine and dopamine release was studied in mice carrying deletions in the genes encoding the three alpha(2)-adrenergic receptor subtypes. Autoradiography and radioligand binding studies showed that alpha(2)-receptor density in alpha(2A)-deficient brains was decreased to 9 +/- 1% of the respective wild-type value, whereas alpha(2)-receptor levels were reduced to 83 +/- 4% in alpha(2C)-deficient mice. These results indicate that approximately 90% of mouse brain alpha(2)-receptors belong to the alpha(2A) subtype and 10% are alpha(2C)-receptors. In isolated brain cortex slices from wild-type mice a non-subtype-selective alpha(2)-receptor agonist inhibited release of [(3)H]norepinephrine by maximally 96%. Similarly, release of [(3)H]dopamine from isolated basal ganglion slices was inhibited by 76% by an alpha(2)-receptor agonist. In alpha(2A)-receptor-deficient mice, the inhibitory effect of the alpha(2)-receptor agonist on norepinephrine and dopamine release was significantly reduced but not abolished. Only in tissues from mice lacking both alpha(2A)- and alpha(2C)-receptors was no alpha(2)-receptor agonist effect on transmitter release observed. The time course of onset of presynaptic inhibition of norepinephrine release was much faster for the alpha(2A)-receptor than for the alpha(2C)-subtype. After prolonged stimulation with norepinephrine, presynaptic alpha(2C)-adrenergic receptors were desensitized. From these data we suggest that two functionally distinct alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), operate as presynaptic inhibitory receptors regulating neurotransmitter release in the mouse CNS.
PMID:11927164 [PubMed - indexed for MEDLINE]
Alpha-2A and Alpha-2C blockade results in an increase in epinephrine/Norepinephrine, Basal Ganglia Dopamine, and serotonin levels. The primary perceived effect, for me, is an increase in motivation and goal-fulfillment actions.
The difference in affinities also can explain Alpha-Yohimbine's distinct lack of anxiety effects as compared to Yohimbine.
dsade
NutraPlanet Fanatic
the tl;dr:
In contrast, the inhibitory presynaptic feedback loop that tightly regulates neurotransmitter release from adrenergic nerves requires two receptor subtypes, α[SUB]2A[/SUB] and α[SUB]2C[/SUB], with similar but complementary effects.
You blockade the alpha 2 receptor subtypes, and you increase, centrally and peripherally, catecholamine level (and prevent their negative feedback) resulting in a multitude of functional effects.
In contrast, the inhibitory presynaptic feedback loop that tightly regulates neurotransmitter release from adrenergic nerves requires two receptor subtypes, α[SUB]2A[/SUB] and α[SUB]2C[/SUB], with similar but complementary effects.
You blockade the alpha 2 receptor subtypes, and you increase, centrally and peripherally, catecholamine level (and prevent their negative feedback) resulting in a multitude of functional effects.
saludable24
Active member
I just gotta say that I LOVE IT when you show us all sorts of cool info from studies. Having real facts and highlights of issues that are involved in different supplement ingredients and their effects is a great tool.
dsade
NutraPlanet Fanatic
You will have a simplified writeup soon. I realized when I lost all of my RPN files, I also lost the old writeup.
Of all of the things I brought to this industry, I am most proud of Alpha-Yohimbine. AlphaBurn is something I take consistently, year round, and find it hard to function without - especially in the morning.
3clipseGT
On my grind
I gotta get on that type of regimen!
MidwestBeast
Legend
lol me too, man.
dsade
NutraPlanet Fanatic
My primary motivator behind my Alpha-Yohimbine research...
Invalid Link Removed
[h=2]Abstract[/h]The α[SUB]2[/SUB] agonist clonidine has been shown to be anxiolytic in a number of preclinical anxiety models. Interestingly, intravenous infusion of the α[SUB]2[/SUB] antagonists idazoxan at 10 mg/kg and rauwolscine at 2.24 mg/kg significantly disinhibited lick-shock conflict responding in rats similar to the α[SUB]2[/SUB] agonist clonidine (0.022 mg/kg) and the benzodiazepine diazepam (0.5 mg/kg). However, the α[SUB]2[/SUB] antagonists yohimbine and piperoxan, the α[SUB]2[/SUB] agonists medetomidine, guanfacine, and guanabenz, the non-specific α antagonist phentolamine, and the α[SUB]1[/SUB] antagonist prazosin did not disinhibit conflict responding in the Vogel lick-shock paradigm. In fact, yohimbine has been shown to be anxiogenic in both animals and man. This may be due to yohimbine's lack of specificity and its ability to inhibit GABAergic release. In addition, all of these agents, except idazoxan, did not increase water consumption in water deprived rats. Idazoxan (10 mg/kg) significantly decreased water consumption by 45%. Therefore, idazoxan increased conflict responding for water reward at a dose (10 mg/kg) which also decreased water consumption in a non-conflict paradigm. These data suggest that agents with selective antagonism at the α[SUB]2[/SUB] receptor site may be anxiolytic while agents with less specificity at this site such as yohimbine, piperoxan, and phentolamine are not anxiolytic.
Basically, Yohimbine causes massive increases in anxiety (anxiogenic)whereas Alpha-Yohimbine is actually anxiolytic.
Invalid Link Removed
[h=2]Abstract[/h]The α[SUB]2[/SUB] agonist clonidine has been shown to be anxiolytic in a number of preclinical anxiety models. Interestingly, intravenous infusion of the α[SUB]2[/SUB] antagonists idazoxan at 10 mg/kg and rauwolscine at 2.24 mg/kg significantly disinhibited lick-shock conflict responding in rats similar to the α[SUB]2[/SUB] agonist clonidine (0.022 mg/kg) and the benzodiazepine diazepam (0.5 mg/kg). However, the α[SUB]2[/SUB] antagonists yohimbine and piperoxan, the α[SUB]2[/SUB] agonists medetomidine, guanfacine, and guanabenz, the non-specific α antagonist phentolamine, and the α[SUB]1[/SUB] antagonist prazosin did not disinhibit conflict responding in the Vogel lick-shock paradigm. In fact, yohimbine has been shown to be anxiogenic in both animals and man. This may be due to yohimbine's lack of specificity and its ability to inhibit GABAergic release. In addition, all of these agents, except idazoxan, did not increase water consumption in water deprived rats. Idazoxan (10 mg/kg) significantly decreased water consumption by 45%. Therefore, idazoxan increased conflict responding for water reward at a dose (10 mg/kg) which also decreased water consumption in a non-conflict paradigm. These data suggest that agents with selective antagonism at the α[SUB]2[/SUB] receptor site may be anxiolytic while agents with less specificity at this site such as yohimbine, piperoxan, and phentolamine are not anxiolytic.
Basically, Yohimbine causes massive increases in anxiety (anxiogenic)whereas Alpha-Yohimbine is actually anxiolytic.
Geoforce
Well-known member
When Matt brought Alpha Y to the market as Alphaburn many users started adding it in to enhance their fat burners. Stacking Alphaburn with pretty much any fat burner was a tactic many people used with many different products. The same uses for the product still exist. It's a solid product on it's own, but a fantastic addition to any cutting stack. It's also been the product since I've been working with Matt for close to a year now that I have gotten more PM's on than any other. "When's Alphaburn coming back?" Finally we can say it's back!
dsade
NutraPlanet Fanatic
Alphaburn was the first isolated Alpha-Yohimbine product. We first released it in 2003-2004 under Avant Labs as the original HEAT Stack.
I purposely left the pricing extremely reasonable for the customers, as I consider this staple product and staple products shouldn't bankrupt us, especially with the new taxes hitting everyone.
I purposely left the pricing extremely reasonable for the customers, as I consider this staple product and staple products shouldn't bankrupt us, especially with the new taxes hitting everyone.
howwedo107
Well-known member
Got mine today I noticed a decrease in appetite cravings from my first dose it was nice! Excited to lift tomorrow with this
dsade
NutraPlanet Fanatic
Let me know how it works, especially in the morning, with motivation.
When I first got this compound, back in 2003, there wasn't a whole lot of information about it other than the receptor affinities and areas of the brain it effects. About 45 minutes after taking the first dose, I always notice this RUSH of motivation that i love. Gotta love activating dopamine centers of the brain!!
howwedo107
Well-known member
Honestly that's funny bc I SWEAR I didn't wanna do any of my "honeydos" today but after my dose I ended up vacuuming and cleaning the litter box haha now how long can I run this? Thinking of picking up 2-3 more bottles with my next NP order
dsade
NutraPlanet Fanatic
You can run it indefinitely. There is no tolerance.
MidwestBeast
Legend
Challenge accepted!
howwedo107
Well-known member
dsade
NutraPlanet Fanatic
New staple acquired then
Disregard females, acquire staples.
MidwestBeast
Legend
Then discussion there shall be.
domore
Well-known member
Discussion shall commence!
NP is still running Alphaburn at 12.99/bottle if you purchase two. Great deal for 200 caps!
dsade
NutraPlanet Fanatic
Those are almost gone, and that will end the intro sale.
Regular price will be at least $17.99
domore
Well-known member
All the more reason to jump on this deal!
MidwestBeast
Legend
MidwestBeast
Legend
I don't know of a timeline off the top of my head, but we'll keep this thread updated.